Omega-3 for Skin & Hair: EPA, DHA and the Skin Barrier

Your skin is the largest organ in your body — and it consists to a considerable extent of fatty acids. Omega-3 fatty acids, in particular EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), are central structural components of the cell membranes in the epidermis and dermis. A deficiency of these essential fatty acids can show up as dry, flaky skin, an increased tendency towards inflammation and reduced wound-healing capacity. At the same time, EPA and DHA are described in connection with hair follicles and nail structure. In this article, you will learn what role omega-3 plays at the level of the skin barrier, what individual studies have observed regarding inflammatory skin processes, and how the research on fatty acids, hair and nails should be interpreted — factually and without any promise of healing.

Omega-3 as a Building Block of the Skin Barrier

Human skin consists of several layers — the epidermis, dermis and subcutis. The epidermis forms the outer protective layer of the body and contains a complex lipid matrix that retains moisture and repels harmful substances. This so-called skin barrier works like a brick wall: keratinocytes (skin cells) are the bricks, and the lipid matrix — consisting of ceramides, fatty acids and cholesterol — is the mortar between them.

Omega-3 fatty acids, especially EPA and DHA, are direct components of the phospholipids in these cell membranes. The higher the proportion of EPA and DHA in the membranes of keratinocytes, the more fluid and flexible these cells are — and the better the barrier function can be maintained. When omega-3 supply is inadequate, more saturated fatty acids or omega-6 fatty acids such as arachidonic acid are incorporated into the membranes instead. The result: stiffer cell membranes, impaired barrier function and increased transepidermal water loss (TEWL).

Transepidermal Water Loss and Moisture Retention

Transepidermal water loss (TEWL) is a measure of how much water evaporates through the skin. An intact skin barrier keeps TEWL low — moisture stays in the skin. In individual observational studies, an association between an elevated TEWL rate and lower omega-3 levels in the blood has been described. Such correlations do not prove a causal relationship.

DHA is concentrated in the cell membranes of the dermis — the deeper skin layer — and is studied in connection with membrane fluidity and the cell's water balance. In studies, DHA deficiency is linked with subjectively dry, dull skin; there is no EFSA-approved health claim for this.

Dry and Flaky Skin: The Most Common Deficiency Sign

Dry, flaky or itchy skin is one of the most frequently described signs of omega-3 deficiency. In animal studies, a diet without essential fatty acids leads to pronounced scaling, increased TEWL and inflammation-like skin changes. In humans, the direct relationship is harder to measure, as changes in skin appearance can have many causes — but epidemiological data show that people with a low omega-3 index more frequently report dry skin.

In nutritional medicine literature, rough skin changes are sometimes described as a possible sign of a deficiency of essential fatty acids. GLA (gamma-linolenic acid), an omega-6 fatty acid, is also studied in this context. Studies describe that GLA and EPA act together in fatty acid metabolism — GLA in connection with keratinocytes and EPA with the formation of pro-inflammatory eicosanoids. These associations are not conclusively established.

EPA and the Eicosanoid Metabolism of the Skin

Inflammatory processes are regarded as a central link between fatty acid metabolism and the skin. Studies describe that EPA (eicosapentaenoic acid) can intervene in the formation of pro-inflammatory signalling molecules in two ways:

1. Displacement of Arachidonic Acid

Arachidonic acid (AA), an omega-6 fatty acid, is the direct precursor of series-2 prostaglandins and series-4 leukotrienes — both pro-inflammatory mediators that can be elevated in inflamed skin areas. EPA competes with arachidonic acid for the enzymes COX (cyclooxygenase) and LOX (lipoxygenase). When EPA is processed via these enzymes, series-3 prostaglandins and series-5 leukotrienes are formed instead, which are considered less pro-inflammatory. Studies describe that a higher EPA intake can shift the biochemical balance in fatty acid metabolism.

2. Formation of Resolvins and Protectins

From EPA and DHA, specialised pro-resolving mediators (SPMs) are formed — including resolvins of the E and D series and protectins. In basic research these molecules take part in the resolution of inflammatory processes: there they limit the influx of neutrophils and stimulate the clearance of cell debris (Serhan, Nature, 2014, PMID 24899309). This does not show that the same happens in human skin. More on the action of these mediators on inflammatory markers in general can be found in the article Omega-3 and Inflammation.

The Evidence on EPA and Inflammatory Skin Processes

Inflammatory skin processes are linked in research to fatty acid metabolism. Local inflammatory reactions involve, among other things, pro-inflammatory eicosanoids — and this is precisely where EPA and DHA intervene biochemically in fatty acid metabolism. There are individual studies on this association, which are interpreted cautiously below.

The mechanism discussed in studies is not associated with any antibacterial activity — EPA does not act on skin bacteria. Only an influence on fatty acid metabolism and the formation of inflammation-associated messenger substances is described. According to current knowledge, keratinisation processes are not affected.

Nutritional research also discusses the omega-6/omega-3 ratio, which in the modern diet is often 15:1 to 20:1 instead of the evolutionarily assumed 4:1. A high omega-6 proportion is associated with a pro-inflammatory milieu in fatty acid metabolism. These associations are the subject of research and are not conclusively established.

The Evidence on Atopic Dermatitis

Atopic dermatitis is a frequently studied topic in fatty acid research. In observational studies, an altered plasma fatty acid profile has been described in those affected — EPA and DHA were often lower, pro-inflammatory arachidonic acid metabolites higher. Such observations do not prove a causal relationship.

The overall data are inconsistent: some intervention studies reported changes in symptoms, others found no differences, and study quality varies considerably. Omega-3 is not a medicine and not a therapy. For skin conditions, medical or dermatological treatment is decisive; dietary supplements do not replace it.

EPA in Eicosanoid Metabolism

At the biochemical level, EPA and DHA intervene in eicosanoid metabolism: EPA competes with arachidonic acid for the processing enzymes, so that fewer strongly pro-inflammatory messenger substances are formed in the cell membranes. This mechanism is the subject of basic research and describes general fatty acid biology, not the treatment of a particular disease.

In observational studies, it has been reported that plasma EPA levels can be lower in people with chronic inflammatory skin processes. Such correlations do not allow conclusions about a benefit of intake. There is no EFSA-approved health claim for omega-3 and the skin; a therapeutic effect is not proven.

DHA in the Dermis: Moisture Retention and Elasticity

Whilst EPA is primarily studied in connection with eicosanoid metabolism, DHA is attributed a more structural role in the dermis — the middle skin layer, which contains collagen fibres, elastic fibres and fibroblasts. DHA is concentrated in the phospholipids of the fibroblast cell membranes. In studies, an association with the production of hyaluronic acid and other glycosaminoglycans, which play a role in moisture binding within the tissue, is discussed.

With increasing age, the fatty acid composition of the skin changes. An adequate DHA supply is described in connection with normal cell membrane function — a promise of benefit in the sense of "rejuvenation" cannot be derived from this, and there is no EFSA-approved health claim.

Omega-3 and Sunburn Sensitivity in Studies

A frequently cited area of research around omega-3 and the skin concerns sunburn sensitivity. UV-B radiation triggers reactions in the skin that manifest as erythema (sunburn) and are mediated, among other things, by pro-inflammatory eicosanoids such as prostaglandin E2 (PGE2). Whether omega-3 intake influences this reaction has been investigated in individual studies.

The influence of EPA on PGE2 formation is discussed as a possible explanatory approach. However, such an association is not conclusively established and is no substitute for sunscreen or physical sun protection. A promise of benefit cannot be derived from this.

The question of whether omega-3 intake influences UV-related changes in skin cells is also the subject of individual studies. The data are limited and not sufficient for a firm statement; there is no EFSA-approved health claim.

Omega-3, Hair and Hair Follicles

Hair consists of about 65–95 % keratin — a protein. The formation of hair requires, in addition to proteins, a functioning microcirculation in the scalp that supplies the hair follicles with nutrients. EPA and DHA are studied in connection with vascular function — a direct link to follicle supply is not thereby proven, however.

EPA and DHA are components of cell membranes, including in the cells of the hair follicles. Hair quality depends on numerous factors — genetic predisposition, hormonal changes, stress and the supply of various nutrients (including iron and zinc) all play a role. Persistent or increased hair loss should be medically investigated; a dietary supplement does not replace this investigation.

Brittle Nails and Omega-3

Nails, like hair, are composed of keratin and are produced from the nail matrix — a specialised tissue at the base of the nail. Adequate blood flow to the nail matrix and intact cell membrane function of the matrix cells are prerequisites for strong, smooth nails.

Brittle, cracked or slow-growing nails are described in nutritional medicine literature as possible signs of omega-3 deficiency. Clinical intervention studies specifically on omega-3 and nail health are scarce — most evidence is anecdotal or from observational studies. What appears biologically plausible: the same membrane fluidity that EPA and DHA improve in skin and hair follicle cells also affects the nail matrix cells.

GLA Deficiency and Skin Problems in Children

In addition to omega-3, GLA (gamma-linolenic acid), an omega-6 fatty acid, is also discussed in fatty acid research. GLA is formed in the body from linoleic acid (LA) via the enzyme delta-6-desaturase. In observational studies, altered delta-6-desaturase activity and lower GLA levels have been described in certain skin changes.

At the biochemical level, GLA is attributed an influence on keratinocytes and fatty acid metabolism. There are individual studies on the combination of GLA and EPA; a proven benefit cannot be derived from this, and there is no EFSA-approved health claim. More on omega-3 deficiency symptoms can be found in our detailed article.

Summary of Studies

Study / Source	Design	Topic	Key Finding
Khayef et al. 2012 Lipids Health Dis, PMID 23206895	Pilot study	EPA and inflammatory skin lesions	No significant overall change; inconsistent individual responses
Gunaratne et al. 2015 Cochrane Database Syst Rev, PMID 26197477	Review	Prenatal omega-3 intake	Review reported differences in atopic reactions
Rhodes et al. 1994 J Invest Dermatol, PMID 8040603	Intervention study	Fish oil and UV protection	Increased minimal erythema dose
Le Floc'h et al. 2015 J Cosmet Dermatol, PMID 25573272	Controlled study	Omega-3/6 combination preparation, hair	Study reported lower telogen fraction

Dosage: How Much EPA and DHA for the Skin?

Since EFSA has not approved a specific dosage claim for skin and hair, there is no official recommendation. The skin studies described above generally used 1 to 3 g of EPA+DHA per day — similar to the inflammation studies, which makes biological sense since the mechanism is identical.

General recommendations from nutrition bodies (such as the German Nutrition Society, DGE) are at least 250 mg EPA+DHA per day — achieved through 1 to 2 portions of oily sea fish per week. Some of the studies mentioned used higher amounts; such study doses are not a usage recommendation. The precise dosage question — also depending on your own omega-3 index — is answered in our article Omega-3 Deficiency: Symptoms and Signs.

The Omega-3 Index: Knowing Your Own Status

Before supplementing at higher doses, it is worth knowing your actual omega-3 status. The omega-3 index — measured as the percentage of EPA+DHA in all fatty acids in red blood cells — is the most reliable marker of long-term omega-3 supply. In the UK, the average value is around 5–6 %, which falls below the optimal range of 8 % and above.

A low omega-3 index explains why many people do not benefit from the advantages of an optimal omega-3 supply despite occasional fish consumption. Checking your own index — for example via an omega-3 deficiency check or a blood test — provides clarity on whether and at what dose to supplement.

Frequently Asked Questions

Scientific Sources

The statements made in this article are based on the following peer-reviewed studies listed in PubMed:

1. Khayef G, Young J, Burns-Whitmore B, Spalding T (2012): Effects of fish oil supplementation on inflammatory acne. Lipids in Health and Disease, 11:165. PMID 23206895
2. Gunaratne AW, Makrides M, Collins CT (2015): Maternal prenatal and/or postnatal n-3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood. Cochrane Database of Systematic Reviews, (7):CD010085. PMID 26197477
3. Rhodes LE, O'Farrell S, Jackson MJ, Friedmann PS (1994): Dietary fish-oil supplementation in humans reduces UVB-erythemal sensitivity but increases epidermal lipid peroxidation. Journal of Investigative Dermatology, 103(2):151–154. PMID 8040603
4. Le Floc'h C, Cheniti A, Connétable S, Piccardi N, Vincenzi C, Tosti A (2015): Effect of a nutritional supplement on hair loss in women. Journal of Cosmetic Dermatology, 14(1):76–82. PMID 25573272